EDGAR Filing Documents for 0001104659-23-101208

Form 8-K - Current report:

SEC Accession No. 0001104659-23-101208

Filing Date

2023-09-15

Accepted

2023-09-15 16:22:06

Documents

Period of Report

2023-09-14

Items

Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tm2326218d1_8k.htm iXBRL	8-K	37850
2	EXHIBIT 3.1	tm2326218d1_ex3-1.htm	EX-3.1	8339
3	EXHIBIT 10.1	tm2326218d1_ex10-1.htm	EX-10.1	9624
	Complete submission text file	0001104659-23-101208.txt		240035

Data Files

Seq	Description	Document	Type	Size
4	XBRL TAXONOMY EXTENSION SCHEMA	ptpi-20230914.xsd	EX-101.SCH	3027
5	XBRL TAXONOMY EXTENSION LABEL LINKBASE	ptpi-20230914_lab.xml	EX-101.LAB	34240
6	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	ptpi-20230914_pre.xml	EX-101.PRE	22367
8	EXTRACTED XBRL INSTANCE DOCUMENT	tm2326218d1_8k_htm.xml	XML	3529

Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036

Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005

Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)